Zdrowie i gospodarka · 04/12/2020

FDA Renewal of Pharmacy Compounding Advisory Committee

The Food and Drug Administration (FDA) is renewing the Pharmacy Compounding Advisory Committee for an additional 2 years, with the new charter set to expire on April 25, 2024, following the Commissioner's determination that it is in the public interest.